Transfusion Medicine

Aims & Scope

Transfusion Medicine publishes articles on transfusion medicine in its widest context, including blood transfusion practice (blood procurement, pharmaceutical, clinical, scientific, computing and documentary aspects), immunohaematology, immunogenetics, histocompatibility, medico-legal applications, and related molecular biology and biotechnology.

In addition to original articles, which may include brief communications and case reports, the journal contains a regular educational section (based on invited reviews and state-of-the-art reports), technical section (including quality assurance and current practice guidelines), leading articles, letters to the editor, occasional historical articles and signed book reviews.

Some lectures from Society meetings that are likely to be of general interest to readers of the Journal may be published at the discretion of the Editor and subject to the availability of space in the Journal.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.4
2024	1.50

SJR (SCImago Journal Rank)

Year	Value
2024	0.434

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	67

Journal Rank

Year	Value
2024	13030

Journal Citation Indicator

Year	Value
2024	254

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Transfusion‐transmitted hepatitis E in a ‘nonhyperendemic’ country

  Citation: 248

  Authors: E., A., G., G., D., S., C.‐G.

• The relationship between ABO histo‐blood group, factor VIII and von Willebrand factor

  Citation: 233

  Authors: J., M. A.

• ABO‐incompatibility in solid organ transplantation

  Citation: 199

  Authors: L.

• Erythrocyte ageing<i>in vivo</i>and<i>in vitro</i>: structural aspects and implications for transfusion

  Citation: 188

  Authors: G. J. C. G. M., J. M., F. L. A., V. M. J.

• <scp>BCSH</scp> guideline for the use of anti‐D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn

  Citation: 172

  Authors: H., E., D., T., S., J., J., S.

• DEHP‐plasticised PVC: relevance to blood services^*

  Citation: 154

  Authors: J., D.

• Guidelines for pre‐transfusion compatibility procedures in blood transfusion laboratories

  Citation: 149

  Authors: C., J., C., C., R., J., M., M., N.

• Analysis of granulocyte‐reactive antibodies using an immunoassay based upon monoclonal‐antibody‐specific immobilization of granulocyte antigens

  Citation: 148

  Authors: J., B., V., C.

• Guidelines on gamma irradiation of blood components for the prevention of transfusion‐associated graft‐versus‐host disease

  Citation: 144

  Authors: J., R. D., K., P., S. M., J. A. F., P., R., M. F., A. H., J. K., L. M., T., A., P., K., B., S., G., D., A., A., R., D.

• Red blood cell storage and cell morphology

  Citation: 139

  Authors: B., A., N., L.

---